Andrew York is the Executive Director of the Maryland Prescription Drug Affordability Board, which is an independent agency charged with protecting Marylanders from the high costs of prescription drugs. Previously, Andrew worked on prescription drug payment policy and drug pricing reform at the Department of Health and Human Services (HHS) working on the Drug Pricing Blueprint and at Center for Medicare & Medicaid Innovation (CMMI) as the model co-lead of the Most Favored Nation Model. Andrew received his PharmD from the University of Maryland School of Pharmacy and his JD from the University of Maryland Francis King Carey School of Law.